Compl'Alim: How to Declare My Dietary Supplements in France? Teleicare Becomes Compl'Alim

Published 
July 16, 2024

What is Compl'Alim? The Registration Platform

 

Compl'Alim is a state startup sponsored by the DGAL. In response to growing concerns about safety and transparency in this expanding sector, Compl'Alim aims to replace the current tool Teleicare by providing more modern and effective solutions.

 

The Dietary Supplements Market in France

 

Key Figures and Trends

 

In 2023, the French dietary supplements market generated a turnover of €2.7 billion, with a growth of 3% compared to the previous year. This sector is experiencing continuous growth, driven by increased demand for wellness and health products. Distribution channels are diversifying, with a strong presence in pharmacies, specialty stores, and increasingly on online platforms.

 

Current Issues: The Challenges of Dietary Supplement Regulation

 

However, this rapid growth comes with challenges, particularly in terms of regulation and public safety. Consumers can be exposed to risks due to misuse or interactions with medications. The current regulatory framework also has gaps, being considered less rigorous than that applied to medicines. Unlike medicines, dietary supplements do not require Marketing Authorization (MA) to be sold, provided they contain authorized ingredients and quantities.

 

How Does Compl'Alim Improve the Regulation of Dietary Supplements?

 

Mission and Objectives

 

Compl'Alim aims to optimize the notification of dietary supplements in France. Its missions include facilitating the processing of dossiers, empowering industry professionals, and informing consumers. Compl'Alim is committed to making the declaration process more efficient and transparent.

 

Technological Innovations

 

To achieve its objectives, the startup has developed a new database, a powerful search engine, and an automated pathway for declaring dietary supplements. These tools allow for better traceability and easier access to information for all market players.

 

The main innovations include:

- A search engine dedicated to ingredients and substances.

- Automatic guidance towards the appropriate declaration procedure based on product composition.

 

Replacement of Teleicare by Compl'Alim

 

Compl'Alim plans to replace Teleicare, the current tool for declaring dietary supplements, which has become outdated. The goal is to modernize, simplify, and make the process of dossier processing and control more efficient. Teleicare no longer meets current regulatory challenges, and Compl'Alim offers solutions to address this situation.

 

What Are the Next Steps for Compl'Alim?

 

Transparency and Accessibility

 

Thanks to Compl'Alim's efforts, the transparency and accessibility of data will be significantly improved. Industry professionals will have access to clear and detailed information, while consumers will benefit from greater safety and confidence in the products they use.

 

Future Developments

 

Compl'Alim has several future development phases planned. Among them are the creation of an open data catalog and the implementation of a system allowing consumers to report undeclared products. These initiatives aim to enhance transparency and collaboration within the industry.

 

Long-Term Objectives

 

Compl'Alim's vision is to become the primary tool for declaring dietary supplements by September 2024. To achieve this goal, key milestones in various development and online projects are planned from March 2024 to January 2025.

 

1. Launch of the substance search engine V0:

  - Period: March to September 2024

  - Users: Professionals, Administration, Data Reusers

 

2. Reliability of the substance database:

  - Period: March to September 2024

  - Users: Professionals, Administration

 

3. Launch of the market entry tool for cases:

  - Period: September 2024 to January 2025

  - Users: Professionals, Administration

 

4. Generation of QR codes for case identification:

  - Period: September 2024 to January 2025

  - Users: Professionals, Consumers

 

5. Online listing of declared and authorized cases:

  - Period: September 2024 to January 2025

  - Users: Data Reusers, Consumers

 

Discover Compl'Alim's roadmap in this article: "Compl'Alim: Towards the Circulation of Dietary Supplements that Comply with Regulations, Are Safe for Public Health, and Adapted to Consumers' Physiological Needs."

 

In summary, Compl'Alim plays a crucial role in improving the notification procedure for dietary supplements in France. By implementing innovative technological tools and promoting transparency, this startup is committed to enhancing public safety and consumer confidence.

Encore +

Articles similaires

Tous
REACH Authorization
10
/
8
/
2024

Latest Regulatory News on Chrome VI: Impact for Users

Hexavalent chromium (CrVI), identified as a carcinogenic, mutagenic and reprotoxic substance under the REACH regulation, remains widely used in industry despite its ban in Europe since 2017. The partial annulment of authorizations by the Court of Justice of the European Union has led to stricter requirements to demonstrate the absence of safe alternatives.
Biocides
9
/
30
/
2024

Biocidal Products: Labels and Claims in the EU

Biocidal products are substances designed to control harmful organisms through chemical or biological means. The regulatory framework governing these products in the EU is primarily based on Regulation (EU) No. 528/2012 (BPR), which outlines the requirements for placing these products on the market, including strict rules on labelling and claims. This article summarizes key points from a recent webinar on the subject, covering the regulatory landscape, labelling requirements, and best practices for making compliant claims.
Cosmetics
9
/
11
/
2024

Understanding the Regulation of Cosmetic Ingredients in Europe: 5 Key Facts

The regulation of cosmetic ingredients in the European Union (EU) is stringent and designed to ensure consumer safety. Cosmetic ingredients are regulated under the EU Cosmetic Product Regulation EU 1223/2009, where ingredients of concern are categorized as prohibited, restricted, or authorized substances, primarily outlined in Annexes II to VI.